Study of Cirmtuzumab and Paclitaxel for Metastatic or Locally Advanced, Unresectable Breast Cancer
Clinical trial NCT02776917 · COMPLETED
Trial details
- NCT number
- NCT02776917
- Sponsor
- Barbara Parker, MD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-15
- Primary completion
- 2021-07-13
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.